Correction: Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation

Frontiers in Pharmacology 2026 Open access

Read full text
Authors: Qiang Zhang, Xinqiao Tang, Zhong Liu, Xiaoxia Song, Dan Peng, Wei Zhu, Zhengxiao Ouyang, Wanchun Wang
DOI: 10.3389/fphar.2025.1678215
Cited by: 0

Abstract

Correction on: Zhang Q, Tang X, Liu Z, Song X, Peng D, Zhu W, Ouyang Z, Wang W. Hesperetin prevents bone resorption by inhibiting RANKL-induced osteoclastogenesis and Jnk mediated Irf-3/c-Jun activation. Front Pharmacol. 2018;9:1028. doi:10.3389/fphar.2018.01028.There was a mistake in Figure 1C (control and 30 μM groups) as published. During figure preparation, the images for the splenocytes control group and the 30 μM group in Figure 1C were incorrectly selected, resulting in a misrepresentation of the experimental data. The corrected Figure1 appears below.for a reason not seen here, please contact the journal's editorial office.

Fields of Study & Subjects

Bone Metabolism and Diseases Bone health and osteoporosis research Bone health and treatments

Publication details

Journal / source
Frontiers in Pharmacology
Volume
16
Pages
1678215–1678215
Publication date
7 January 2026
Language
EN